Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36. doi: 10.1002/ijgo.12611.
Since the publication of the last FIGO Cancer Report there have been giant strides in the global effort to reduce the burden of cervical cancer, with WHO announcing a call for elimination. In over 80 countries, including LMICs, HPV vaccination is now included in the national program. Screening has also seen major advances with implementation of HPV testing on a larger scale. However, these interventions will take a few years to show their impact. Meanwhile, over half a million new cases are added each year. Recent developments in imaging and increased use of minimally invasive surgery have changed the paradigm for management of these cases. The FIGO Gynecologic Oncology Committee has revised the staging system based on these advances. This chapter discusses the management of cervical cancer based on the stage of disease, including attention to palliation and quality of life issues.
自上次 FIGO 癌症报告发布以来,全球在降低宫颈癌负担方面取得了巨大进展,世界卫生组织(WHO)已宣布呼吁消除宫颈癌。在包括中低收入国家在内的 80 多个国家,HPV 疫苗接种已被纳入国家计划。筛查也取得了重大进展,更大规模地实施了 HPV 检测。然而,这些干预措施需要几年时间才能显示出其影响。与此同时,每年新增病例超过 50 万。影像学的新进展和微创手术的广泛应用改变了这些病例的管理模式。FIGO 妇科肿瘤委员会根据这些进展修订了分期系统。本章根据疾病分期讨论宫颈癌的管理,包括对姑息治疗和生活质量问题的关注。